Epigenetic Proteins Product Solutions
Epigenetics involves the study of heritable or acquired changes in gene expression caused by non-genetic mechanisms without alterations in gene structure or sequence. Basic epigenetic mechanisms such as histone modifications, DNA methylation, and chromatin remodeling are essential in the regulation of many physiological processes. Alterations to the mechanisms -- either by modifications to DNA and histone components of nucleosomes, or by expression of noncoding RNAs (ncRNAs) -- can have implications in a number of cancers, immunological, and neurodegenerative conditions.
Eurofins DiscoverX® offers epigenetics recombinant proteins and InCELL Hunter™ cell-based assays for studying the modulation of epigenetic mechanisms and identifying small molecule inhibitors and modifiers of DNA methyltransferases and bromodomains. Utilize InCELL Hunter cell-based compound-target engagement assays to confirm small molecule compound cell entry and epigenetic target binding, screen and rank inhibitors, validate hits identified in biochemical assays, and measure cellular EC50 values all in the native cellular environment.
- Biologically Relevant - Obtain quantitative cellular compound entry and epigenetic target binding data for more confident drug discovery decisions
- Easy-to-Use & Scalable - Simple, homogeneous, and high-throughput amenable protocol to easily measure compound binding to your epigenetic target with a chemiluminescent readout
- Target Specificity & Selectivity - Ability to screen and differentiate multiple target-selective stereoisomers of BRD4 and determine target specificity
- High Quality Proteins - Access epigenetics-related recombinant proteins produced using optimal expression systems with high quality and purity
- Epigenetic Proteins – Recombinant epigenetic proteins, expressed in E. coli and tagged (e.g. GST, His6), and used in EPIscan screening and profiling services (based on the novel InCELL Hunter technology)
- InCELL Hunter Epigenetic Cell Lines – Stable cell lines confirmed for past 10 passages and rigorously and continuously validated for accurate pharmacology through Eurofins Discovery services with billions of data points screened.
- InCELL Hunter eXpress Kits – Complete assay-ready kits with specific cell line, optimized reagents, and plates for quick Enzyme Fragment Complementation (EFC) based chemiluminescent detection.
- InCELL Pulse Starter Kit – Create your own cell-based, target engagement assays with reagents and protocol for the design and development of InCELL Pulse assays for the measurement of inhibitor cellular potency against user-defined epigenetic targets of interest.
- InCELL Detection Kit – Measure compound binding to a specific protein target in InCELL Hunter and InCELL Pulse cell lines
InCELL Hunter Assay Principle
InCELL Hunter stabilization assays are based on the industry validated Enzyme Fragment Complementation (EFC) technology and built on the principle of protein stabilization related to the protein turnover. Cells expressing a protein of interest is fused to the small EFC enzyme donor of β-galactosidase (β-gal) called ePL (enhanced ProLabel®).
Upon addition of a compound that binds the target, protein levels are stabilized or altered in the cell, and this change can be monitored by measuring target protein abundance using chemiluminescent detection. Upon addition of the large EFC enzyme acceptor (EA) fragment and chemiluminescent substrate, EA naturally complements with the ePL tag on the target protein to create an active β-gal enzyme. The resulting active enzyme hydrolyzes the substrate to generate a chemiluminescent signal.
The greater the signal, the greater the presence of compound-target engagement in the cell.
InCELL Pulse Assay Principle
InCELL Pulse™ compound-target engagement assays are based on the EFC technology incorporating compound binding detection based on protein thermal stability. Cells expressing a protein of interest is fused to the small EFC β-gal enzyme donor ePL. These cells are treated with test compound and then subjected to elevated temperatures during a pulse denaturation step.
The larger EFC enzyme donor (EA) of β-gal is then added with a chemiluminescnet substrate and EFC complementation.
Compound binding protects the target protein from thermal denaturation, which enhances complementation between added EA and ePL components and increases the chemiluminescent signal measured using the EFC-based detection system. In the absence of compound binding, the target protein forms denatured aggregates that poorly complement with EA, which results in a low chemiluminescent signal.
It is well established that ligand binding can protect proteins from thermal denaturation in a cellular milieu; however, the broad…Read More
Assays that directly detect compound binding inside cells can be of great utility in translating in vitro data to more…Read More
Ubiquitin-mediated degradation of signaling proteins is a primary means of signal regulation in a wide variety of cellular processes including…Read More
Here we will describe InCELL Pulse™, which uses DiscoverX’s Enzyme Fragment Complementation (EFC) technology to overcome these limitations of current…Watch Now
Kinase inhibitors often potently inhibit several off-target kinases in biochemical assays. Unfortunately, the relevance of these off-target interactions in a…Watch Now
It is well established that ligand binding can protect proteins from thermal denaturation in a cellular milieu; however, the broad…Watch Now
Learn how InCELL cell-based binding assays can be used to detect compound cell entry and engagement to specific targets including…Watch Now
Information on compound-target engagement obtained from traditional in vitro binding assays differs greatly from that in a physiologically relevant model…Read More
Whether you’re looking to screen a library of drug candidates for binding to a particular target protein, checking drug cell…Read More
Cell-based assays are useful for understanding cellular pathways; characterizing targets and their function; identifying, screening, and optimizing ligands or drugs…Read More
A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)Read More
Bromodomain protein 4 (BRD4), a member of the bromodomain and extra-terminal (BET) proteinfamily, acts as a central element in transcriptional…Read More
Robust Cell-Based Assays to Identify Therapeutic Hits RapidlyRead More